Standout Papers

ω-3 Fatty Acid Treatment in 174 Patients With Mild to Moderate Alzheimer Disease: OmegAD Study... 2006 2026 2012 2019 563
  1. ω-3 Fatty Acid Treatment in 174 Patients With Mild to Moderate Alzheimer Disease: OmegAD Study (2006)
    Yvonne Freund‐Levi, Maria Eriksdotter et al. Archives of Neurology

Immediate Impact

3 by Nobel laureates 7 from Science/Nature 54 standout
Sub-graph 1 of 21

Citing Papers

Infant microbes and metabolites point to childhood neurodevelopmental disorders
2024 Standout
Naturally occurring T cell mutations enhance engineered T cell therapies
2024 StandoutNature
22 intermediate papers

Works of Inger Vedin being referenced

The transporter ABCB7 is a mediator of the phenotype of acquired refractory anemia with ring sideroblasts
2012
Effects of docosahexaenoic acid–rich n−3 fatty acid supplementation on cytokine release from blood mononuclear leukocytes: the OmegAD study
2008
and 4 more

Author Peers

Author Last Decade Papers Cites
Inger Vedin 901 832 443 36 1.9k
Karin Yurko‐Mauro 882 778 414 28 1.8k
Anita Garlind 555 771 499 30 1.6k
Erik Hjorth 691 752 543 39 1.9k
Lynne Shinto 478 565 507 48 2.3k
Wei Chen 1039 646 614 34 2.9k
Hana A. Itani 917 477 567 43 2.4k
Jung H. Suh 433 554 1266 59 2.8k
Rafal R. Nazarewicz 333 751 1277 32 2.9k
Cees Mulder 242 921 486 42 1.7k
Mingqin Zhu 359 507 601 55 1.7k

All Works

Loading papers...

Rankless by CCL
2026